Imagion Biosystems Limited has lodged Appendix 4G “Key to Disclosures, Corporate Governance Council Principles and Recommendations” with the Australian Securities Exchange. Read Appendix 4G and Corporate Governance Statement.
The Stock Network Interview – Opening US trial sites for MagSense® breast cancer imaging
October 17, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the